The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dermatology Drug Market Research Report 2025
Synopsis
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
The global Dermatology Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In the US market, the major manufacturers are AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma, Valeant and Leo Pharma.
This report aims to provide a comprehensive presentation of the global market for Dermatology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Drug.
Report Scope
The Dermatology Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatology Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Segment by Type
External Use
Oral
Injection
Segment by Application
Psoriasis
Skin Infections
Acne
Dermatitis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatology Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
The global Dermatology Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In the US market, the major manufacturers are AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma, Valeant and Leo Pharma.
This report aims to provide a comprehensive presentation of the global market for Dermatology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Drug.
Report Scope
The Dermatology Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatology Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Segment by Type
External Use
Oral
Injection
Segment by Application
Psoriasis
Skin Infections
Acne
Dermatitis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatology Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 External Use
1.2.3 Oral
1.2.4 Injection
1.3 Market by Application
1.3.1 Global Dermatology Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatology Drug Market Perspective (2019-2030)
2.2 Dermatology Drug Growth Trends by Region
2.2.1 Global Dermatology Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dermatology Drug Historic Market Size by Region (2019-2024)
2.2.3 Dermatology Drug Forecasted Market Size by Region (2025-2030)
2.3 Dermatology Drug Market Dynamics
2.3.1 Dermatology Drug Industry Trends
2.3.2 Dermatology Drug Market Drivers
2.3.3 Dermatology Drug Market Challenges
2.3.4 Dermatology Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatology Drug Players by Revenue
3.1.1 Global Top Dermatology Drug Players by Revenue (2019-2024)
3.1.2 Global Dermatology Drug Revenue Market Share by Players (2019-2024)
3.2 Global Dermatology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatology Drug Revenue
3.4 Global Dermatology Drug Market Concentration Ratio
3.4.1 Global Dermatology Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology Drug Revenue in 2023
3.5 Dermatology Drug Key Players Head office and Area Served
3.6 Key Players Dermatology Drug Product Solution and Service
3.7 Date of Enter into Dermatology Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatology Drug Breakdown Data by Type
4.1 Global Dermatology Drug Historic Market Size by Type (2019-2024)
4.2 Global Dermatology Drug Forecasted Market Size by Type (2025-2030)
5 Dermatology Drug Breakdown Data by Application
5.1 Global Dermatology Drug Historic Market Size by Application (2019-2024)
5.2 Global Dermatology Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dermatology Drug Market Size (2019-2030)
6.2 North America Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Dermatology Drug Market Size by Country (2019-2024)
6.4 North America Dermatology Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatology Drug Market Size (2019-2030)
7.2 Europe Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Dermatology Drug Market Size by Country (2019-2024)
7.4 Europe Dermatology Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatology Drug Market Size (2019-2030)
8.2 Asia-Pacific Dermatology Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Dermatology Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Dermatology Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermatology Drug Market Size (2019-2030)
9.2 Latin America Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Dermatology Drug Market Size by Country (2019-2024)
9.4 Latin America Dermatology Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatology Drug Market Size (2019-2030)
10.2 Middle East & Africa Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Dermatology Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Dermatology Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Dermatology Drug Introduction
11.1.4 AbbVie Revenue in Dermatology Drug Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Dermatology Drug Introduction
11.2.4 Johnson & Johnson Revenue in Dermatology Drug Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Dermatology Drug Introduction
11.3.4 Bayer Revenue in Dermatology Drug Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Galderma
11.4.1 Galderma Company Detail
11.4.2 Galderma Business Overview
11.4.3 Galderma Dermatology Drug Introduction
11.4.4 Galderma Revenue in Dermatology Drug Business (2019-2024)
11.4.5 Galderma Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Dermatology Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Dermatology Drug Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Dermatology Drug Introduction
11.6.4 Novartis Revenue in Dermatology Drug Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Dermatology Drug Introduction
11.7.4 Pfizer Revenue in Dermatology Drug Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Merz Pharma
11.8.1 Merz Pharma Company Detail
11.8.2 Merz Pharma Business Overview
11.8.3 Merz Pharma Dermatology Drug Introduction
11.8.4 Merz Pharma Revenue in Dermatology Drug Business (2019-2024)
11.8.5 Merz Pharma Recent Development
11.9 Valeant
11.9.1 Valeant Company Detail
11.9.2 Valeant Business Overview
11.9.3 Valeant Dermatology Drug Introduction
11.9.4 Valeant Revenue in Dermatology Drug Business (2019-2024)
11.9.5 Valeant Recent Development
11.10 LEO Pharma
11.10.1 LEO Pharma Company Detail
11.10.2 LEO Pharma Business Overview
11.10.3 LEO Pharma Dermatology Drug Introduction
11.10.4 LEO Pharma Revenue in Dermatology Drug Business (2019-2024)
11.10.5 LEO Pharma Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Dermatology Drug Introduction
11.11.4 GlaxoSmithKline Revenue in Dermatology Drug Business (2019-2024)
11.11.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
